TGFB1 and abdominal aortic aneurysm: Similarly, a recent experiment by Da et al. on the treatment of abdominal aortic aneurysms (TAA) in mice found that the application of AGGF could inhibit vascular inflammation and remodeling of TAA by blocking the cleavage of LAP‐TGF‐β1 to form mature TGF‐β1 and inhibiting Smad2/3 and ERK1/2 phosphorylation in VSMCs.46